Translational Informatics and Biometrics
Unlock the power of your multiomic data
Unlocking the Value of Complex Biomarker Data: Clinical Omics
In this article, our experts are asked to explore biomarker data trends and
challenges, and share how drug developers evaluating biomarkers in
early-phase studies can quickly realize the full value of the collected data.
The proliferation of biomarker data presents a massive challenge for teams compiling data sets from multiple labs covering several assay types and numerous time points. Today’s multiomic approach demands the harmonization of these data sets as well as relevant clinical annotation for subsequent interrogation–including leveraging the power of artificial intelligence-driven analysis. QuartzBioSM is the market leader in unraveling biomarker and meta data to generate actionable, analytic-ready data sets.
Multiomic data integration and informatics
- Leverage deep domain expertise to harmonize large, complex multiomic data sets within and across trials (covering flow cytometry, genomics, gene expression profiling, imaging, clinical annotations, and beyond)
- Dramatically reduce time to consolidate data from multiple labs for internal analysis–from days or weeks to minutes–to maximize on-study utility
- Create analysis- and submission-ready data sets (including CDISC) using a secure 21 CFR Part 11 compliant infrastructure
- Generate AI-derived signatures across integrated omic data sets and explore results in an intuitive, interpretable, and interactive interface
Comprehensive multiomic data ingestion, harmonization, and the ability to uncover mechanisms of action, identify biomarkers, and stratify patients
Find out more about QuartzBio
